{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T09:21:39Z","timestamp":1785835299639,"version":"3.56.0"},"reference-count":198,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ackdjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Chronic Kidney Disease"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1053\/j.ackd.2018.08.010","type":"journal-article","created":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T19:33:30Z","timestamp":1539027210000},"page":"454-467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Working Toward an Improved Understanding of Chronic Cardiorenal Syndrome Type 4"],"prefix":"10.1053","volume":"25","author":[{"given":"Daniel","family":"Edmonston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica D.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Middleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1053\/j.ackd.2018.08.010_bib1","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1053\/j.ackd.2018.08.010_bib2","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2008.07.051","article-title":"Cardiorenal syndrome","volume":"52","author":"Ronco","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.ackd.2018.08.010_bib3","series-title":"National chronic kidney disease fact sheet, 2017","year":"2017"},{"key":"10.1053\/j.ackd.2018.08.010_bib4","series-title":"Heart failure fact sheet: National center for chronic disease prevention and health promotion","year":"2016"},{"issue":"10","key":"10.1053\/j.ackd.2018.08.010_bib5","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.2215\/CJN.04020417","article-title":"Epidemiology and natural history of the cardiorenal syndromes in a cohort with echocardiography","volume":"12","author":"Mavrakanas","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"10.1053\/j.ackd.2018.08.010_bib6","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1093\/ndt\/11.7.1277","article-title":"Outcome and risk factors for left ventricular disorders in chronic uraemia","volume":"11","author":"Parfrey","year":"1996","journal-title":"Nephrol Dial Transpl"},{"issue":"7","key":"10.1053\/j.ackd.2018.08.010_bib7","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jcmg.2013.09.025","article-title":"Defining the natural history of uremic cardiomyopathy in chronic kidney disease: the role of cardiovascular magnetic resonance","volume":"7","author":"Edwards","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"issue":"10","key":"10.1053\/j.ackd.2018.08.010_bib8","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1038\/sj.ki.5000249","article-title":"Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging","volume":"69","author":"Mark","year":"2006","journal-title":"Kidney Int"},{"issue":"10","key":"10.1053\/j.ackd.2018.08.010_bib9","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1681\/ASN.2012020145","article-title":"Associations between kidney function and subclinical cardiac abnormalities in CKD","volume":"23","author":"Park","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"10.1053\/j.ackd.2018.08.010_bib10","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/ndt\/gfh288","article-title":"The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10 year survey","volume":"19","author":"Paoletti","year":"2004","journal-title":"Nephrol Dial Transpl"},{"issue":"6","key":"10.1053\/j.ackd.2018.08.010_bib11","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1053\/ajkd.2002.36881","article-title":"Clinical correlates and mortality impact of left ventricular hypertrophy among new ESRD patients in the United States","volume":"40","author":"Stack","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ackd.2018.08.010_bib12","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1111\/j.1523-1755.2004.00530.x","article-title":"Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression","volume":"65","author":"Zoccali","year":"2004","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ackd.2018.08.010_bib13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1523-1755.2005.00072.x","article-title":"Electrocardiographic abnormalities and uremic cardiomyopathy","volume":"67","author":"Stewart","year":"2005","journal-title":"Kidney Int"},{"issue":"3 suppl 1","key":"10.1053\/j.ackd.2018.08.010_bib14","article-title":"US Renal Data System 2017 Annual Data Report: epidemiology of kidney disease in the United States","volume":"71","author":"Saran","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1053\/j.ackd.2018.08.010_bib15","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/ki.2009.219","article-title":"Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery disease","volume":"76","author":"Pun","year":"2009","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ackd.2018.08.010_bib16","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1161\/01.CIR.90.6.2786","article-title":"Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade","volume":"90","author":"London","year":"1994","journal-title":"Circulation"},{"issue":"1","key":"10.1053\/j.ackd.2018.08.010_bib17","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1523-1755.2005.00086.x","article-title":"Clinical and pathologic characteristics of dilated cardiomyopathy in hemodialysis patients","volume":"67","author":"Aoki","year":"2005","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ackd.2018.08.010_bib18","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jcmg.2008.03.011","article-title":"Patterns of late gadolinium enhancement in chronic hemodialysis patients","volume":"1","author":"Schietinger","year":"2008","journal-title":"JACC Cardiovasc Imaging"},{"issue":"7","key":"10.1053\/j.ackd.2018.08.010_bib19","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/rheumatology\/kem077","article-title":"Myocardial disease in systemic vasculitis and autoimmune disease detected by cardiovascular magnetic resonance","volume":"46","author":"Edwards","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1053\/j.ackd.2018.08.010_bib20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jchf.2014.07.015","article-title":"Mineralocorticoid receptor antagonists modulate galectin-3 and interleukin-33\/ST2 signaling in left ventricular systolic dysfunction after acute myocardial infarction","volume":"3","author":"Lax","year":"2015","journal-title":"JACC Heart Fail"},{"issue":"3","key":"10.1053\/j.ackd.2018.08.010_bib21","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/HYPERTENSIONAHA.115.06161","article-title":"Inhibition of Galectin-3 pathway prevents isoproterenol-induced left ventricular dysfunction and fibrosis in mice","volume":"67","author":"Vergaro","year":"2016","journal-title":"Hypertension"},{"issue":"4","key":"10.1053\/j.ackd.2018.08.010_bib22","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2018.03.025","article-title":"GDF-15, galectin 3, soluble ST2, and risk of mortality and cardiovascular events in CKD","volume":"72","author":"Tuegel","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1053\/j.ackd.2018.08.010_bib23","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/CIRCULATIONAHA.108.807362","article-title":"Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis","volume":"119","author":"Kalantar-Zadeh","year":"2009","journal-title":"Circulation"},{"issue":"3","key":"10.1053\/j.ackd.2018.08.010_bib24","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/ki.2013.336","article-title":"Volume overload correlates with cardiovascular risk factors in patients with chronic kidney disease","volume":"85","author":"Hung","year":"2014","journal-title":"Kidney Int"},{"issue":"12","key":"10.1053\/j.ackd.2018.08.010_bib25","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1681\/ASN.2017060640","article-title":"Dialysate potassium, dialysate magnesium, and hemodialysis risk","volume":"28","author":"Pun","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"10.1053\/j.ackd.2018.08.010_bib26","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1001\/archinternmed.2009.132","article-title":"The frequency of hyperkalemia and its significance in chronic kidney disease","volume":"169","author":"Einhorn","year":"2009","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1053\/j.ackd.2018.08.010_bib27","doi-asserted-by":"crossref","first-page":"762","DOI":"10.2215\/CJN.05850809","article-title":"Serum potassium and outcomes in CKD: insights from the RRI-CKD cohort study","volume":"5","author":"Korgaonkar","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ackd.2018.08.010_bib28","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2215\/CJN.01730215","article-title":"Association between serum potassium and outcomes in patients with reduced kidney function","volume":"11","author":"Luo","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ackd.2018.08.010_bib29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10741-011-9261-3","article-title":"Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome","volume":"17","author":"Colombo","year":"2012","journal-title":"Heart Fail Rev"},{"issue":"9","key":"10.1053\/j.ackd.2018.08.010_bib30","doi-asserted-by":"crossref","first-page":"e0138461","DOI":"10.1371\/journal.pone.0138461","article-title":"Inflammation, endothelial dysfunction and increased left ventricular mass in chronic kidney disease (CKD) patients: a longitudinal study","volume":"10","author":"Ioannou","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1053\/j.ackd.2018.08.010_bib31","doi-asserted-by":"crossref","first-page":"e0124772","DOI":"10.1371\/journal.pone.0124772","article-title":"Association between inflammation and cardiac geometry in chronic kidney disease: findings from the CRIC study","volume":"10","author":"Gupta","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"10.1053\/j.ackd.2018.08.010_bib32","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jacc.2008.04.061","article-title":"Anemia and mortality in heart failure patients a systematic review and meta-analysis","volume":"52","author":"Groenveld","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1053\/j.ackd.2018.08.010_bib33","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2011111078","article-title":"Mechanisms of anemia in CKD","volume":"23","author":"Babitt","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ackd.2018.08.010_bib34","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.amjcard.2007.07.067","article-title":"Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry)","volume":"101","author":"Young","year":"2008","journal-title":"Am J Cardiol"},{"issue":"20","key":"10.1053\/j.ackd.2018.08.010_bib35","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1161\/CIRCULATIONAHA.105.583666","article-title":"Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options","volume":"113","author":"Tang","year":"2006","journal-title":"Circulation"},{"issue":"23","key":"10.1053\/j.ackd.2018.08.010_bib36","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1161\/CIRCULATIONAHA.105.577577","article-title":"Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: outcomes and Resource Utilization (ANCHOR) Study","volume":"113","author":"Go","year":"2006","journal-title":"Circulation"},{"issue":"1","key":"10.1053\/j.ackd.2018.08.010_bib37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0272-6386(96)90130-4","article-title":"The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease","volume":"28","author":"Foley","year":"1996","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 8","key":"10.1053\/j.ackd.2018.08.010_bib38","first-page":"viii7","article-title":"The cardio-renal anaemia syndrome: does it exist?","volume":"18","author":"Silverberg","year":"2003","journal-title":"Nephrol Dial Transpl"},{"issue":"4","key":"10.1053\/j.ackd.2018.08.010_bib39","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.semnephrol.2006.05.006","article-title":"The interaction between heart failure and other heart diseases, renal failure, and anemia","volume":"26","author":"Silverberg","year":"2006","journal-title":"Semin Nephrol"},{"issue":"3","key":"10.1053\/j.ackd.2018.08.010_bib40","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/jama.279.3.217","article-title":"Human cardiovascular and metabolic response to acute, severe isovolemic anemia","volume":"279","author":"Weiskopf","year":"1998","journal-title":"JAMA"},{"issue":"5","key":"10.1053\/j.ackd.2018.08.010_bib41","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3324\/haematol.10915","article-title":"Heart disease in thalassemia intermedia: a review of the underlying pathophysiology","volume":"92","author":"Aessopos","year":"2007","journal-title":"Haematologica"},{"issue":"3","key":"10.1053\/j.ackd.2018.08.010_bib42","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/CIR.0b013e31829b2be6","article-title":"Cardiovascular function and treatment in beta-thalassemia major: a consensus statement from the American Heart Association","volume":"128","author":"Pennell","year":"2013","journal-title":"Circulation"},{"issue":"3","key":"10.1053\/j.ackd.2018.08.010_bib43","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.hfc.2010.03.002","article-title":"Pathophysiology of anemia in heart failure","volume":"6","author":"Anand","year":"2010","journal-title":"Heart Fail Clin"},{"issue":"1","key":"10.1053\/j.ackd.2018.08.010_bib44","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0272-6386(99)70118-6","article-title":"Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin","volume":"34","author":"Levin","year":"1999","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1053\/j.ackd.2018.08.010_bib45","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1681\/ASN.2005030226","article-title":"Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney disease","volume":"16","author":"Vlagopoulos","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ackd.2018.08.010_bib46","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1681\/ASN.2004070597","article-title":"Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease","volume":"16","author":"Weiner","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ackd.2018.08.010_bib47","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/ndt\/gfr407","article-title":"Echocardiographic parameters are independently associated with increased cardiovascular events in patients with chronic kidney disease","volume":"27","author":"Chen","year":"2012","journal-title":"Nephrol Dial Transpl"},{"issue":"6","key":"10.1053\/j.ackd.2018.08.010_bib48","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/0735-1097(95)00007-Q","article-title":"Endothelium-derived relaxing factor is important in mediating the high output state in chronic severe anemia","volume":"25","author":"Anand","year":"1995","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1053\/j.ackd.2018.08.010_bib49","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/hrt.70.4.357","article-title":"Pathogenesis of oedema in chronic severe anaemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones","volume":"70","author":"Anand","year":"1993","journal-title":"Br Heart J"},{"issue":"2","key":"10.1053\/j.ackd.2018.08.010_bib50","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1053\/j.ajkd.2014.12.016","article-title":"Cardiorenal syndrome and the role of the bone-mineral Axis and anemia","volume":"66","author":"Charytan","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1053\/j.ackd.2018.08.010_bib51","doi-asserted-by":"crossref","first-page":"e0184076","DOI":"10.1371\/journal.pone.0184076","article-title":"Associations between endothelial dysfunction and clinical and laboratory parameters in children and adolescents with sickle cell anemia","volume":"12","author":"Teixeira","year":"2017","journal-title":"PLoS One"},{"issue":"11","key":"10.1053\/j.ackd.2018.08.010_bib52","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1161\/01.CIR.0000057810.48709.F6","article-title":"Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study","volume":"107","author":"Vasan","year":"2003","journal-title":"Circulation"},{"issue":"11","key":"10.1053\/j.ackd.2018.08.010_bib53","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1161\/01.CIR.0000060808.79274.0C","article-title":"Proinflammatory cytokines: predictors of a failing heart?","volume":"107","author":"Murray","year":"2003","journal-title":"Circulation"},{"issue":"6","key":"10.1053\/j.ackd.2018.08.010_bib54","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/ejhf.84","article-title":"The additive burden of iron deficiency in the cardiorenal-anaemia axis: scope of a problem and its consequences","volume":"16","author":"Klip","year":"2014","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1053\/j.ackd.2018.08.010_bib55","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ahj.2013.01.017","article-title":"Iron deficiency in chronic heart failure: an international pooled analysis","volume":"165","author":"Klip","year":"2013","journal-title":"Am Heart J"},{"issue":"15","key":"10.1053\/j.ackd.2018.08.010_bib56","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/eurheartj\/ehq158","article-title":"Iron deficiency: an ominous sign in patients with systolic chronic heart failure","volume":"31","author":"Jankowska","year":"2010","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1053\/j.ackd.2018.08.010_bib57","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.ijcard.2012.12.091","article-title":"Expansion of the red cell distribution width and evolving iron deficiency as predictors of poor outcome in chronic heart failure","volume":"168","author":"Aung","year":"2013","journal-title":"Int J Cardiol"},{"issue":"12","key":"10.1053\/j.ackd.2018.08.010_bib58","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.jacc.2011.04.040","article-title":"Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival","volume":"58","author":"Okonko","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1053\/j.ackd.2018.08.010_bib59","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ahj.2010.05.022","article-title":"Serum albumin concentration and heart failure risk the health, aging, and body composition study","volume":"160","author":"Gopal","year":"2010","journal-title":"Am Heart J"},{"issue":"5","key":"10.1053\/j.ackd.2018.08.010_bib60","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.cardfail.2014.01.016","article-title":"Hypoalbuminemia in acute heart failure patients: causes and its impact on hospital and long-term mortality","volume":"20","author":"Bonilla-Palomas","year":"2014","journal-title":"J Card Fail"},{"issue":"3","key":"10.1053\/j.ackd.2018.08.010_bib61","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jacc.2004.10.038","article-title":"Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction","volume":"45","author":"Ishani","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1053\/j.ackd.2018.08.010_bib62","doi-asserted-by":"crossref","first-page":"F932","DOI":"10.1152\/ajprenal.00200.2006","article-title":"Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors","volume":"291","author":"Jie","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"10.1053\/j.ackd.2018.08.010_bib63","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ncpneph0655","article-title":"Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure","volume":"4","author":"van der Putten","year":"2008","journal-title":"Nat Clin Pract Nephrol"},{"issue":"Suppl 1","key":"10.1053\/j.ackd.2018.08.010_bib64","first-page":"S93","article-title":"The cardio renal anemia syndrome: correcting anemia in patients with resistant congestive heart failure can improve both cardiac and renal function and reduce hospitalizations","volume":"60","author":"Silverberg","year":"2003","journal-title":"Clin Nephrol"},{"issue":"20","key":"10.1053\/j.ackd.2018.08.010_bib65","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa062276","article-title":"Normalization of hemoglobin level in patients with chronic kidney disease and anemia","volume":"355","author":"Drueke","year":"2006","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1053\/j.ackd.2018.08.010_bib66","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMoa065485","article-title":"Correction of anemia with epoetin alfa in chronic kidney disease","volume":"355","author":"Singh","year":"2006","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1053\/j.ackd.2018.08.010_bib67","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","article-title":"A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease","volume":"361","author":"Pfeffer","year":"2009","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1053\/j.ackd.2018.08.010_bib68","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.ejheart.2007.09.009","article-title":"Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications","volume":"9","author":"Hartog","year":"2007","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10.1053\/j.ackd.2018.08.010_bib69","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10741-010-9225-z","article-title":"Advanced glycation end-products, a pathophysiological pathway in the cardiorenal syndrome","volume":"17","author":"Willemsen","year":"2012","journal-title":"Heart Fail Rev"},{"issue":"2","key":"10.1053\/j.ackd.2018.08.010_bib70","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1681\/ASN.2014101047","article-title":"Uremic toxicity of advanced glycation end products in CKD","volume":"27","author":"Stinghen","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ackd.2018.08.010_bib71","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1681\/ASN.2009121293","article-title":"Forging forward with 10 burning questions on FGF23 in kidney disease","volume":"21","author":"Wolf","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ackd.2018.08.010_bib72","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s40620-014-0075-y","article-title":"Calcium, phosphate and calcium phosphate product are markers of outcome in patients with chronic heart failure","volume":"28","author":"Cubbon","year":"2015","journal-title":"J Nephrol"},{"issue":"5","key":"10.1053\/j.ackd.2018.08.010_bib73","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1053\/ajkd.2001.28588","article-title":"A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients","volume":"38","author":"Stack","year":"2001","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1053\/j.ackd.2018.08.010_bib74","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/ki.2013.3","article-title":"Fibroblast growth factor 23 is not associated with and does not induce arterial calcification","volume":"83","author":"Scialla","year":"2013","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ackd.2018.08.010_bib75","doi-asserted-by":"crossref","first-page":"739","DOI":"10.5301\/jn.5000290","article-title":"Progression of cardiac valve calcification and decline of renal function in CKD patients","volume":"26","author":"Di Lullo","year":"2013","journal-title":"J Nephrol"},{"issue":"2","key":"10.1053\/j.ackd.2018.08.010_bib76","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000197562","article-title":"Phosphate - the silent stealthy cardiorenal culprit in all stages of chronic kidney disease: a systematic review","volume":"27","author":"Kanbay","year":"2009","journal-title":"Blood Purif"},{"issue":"2","key":"10.1053\/j.ackd.2018.08.010_bib77","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1681\/ASN.2004070610","article-title":"Association between chronic kidney disease and coronary artery calcification: the Dallas Heart Study","volume":"16","author":"Kramer","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ackd.2018.08.010_bib78","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1681\/ASN.2008020141","article-title":"Serum phosphorus levels associate with coronary atherosclerosis in young adults","volume":"20","author":"Foley","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ackd.2018.08.010_bib79","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1681\/ASN.2008040349","article-title":"Association of serum phosphate with vascular and valvular calcification in moderate CKD","volume":"20","author":"Adeney","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ackd.2018.08.010_bib80","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/cvr\/cvs240","article-title":"Effects of phosphate on vascular function under normal conditions and influence of the uraemic state","volume":"96","author":"Six","year":"2012","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1053\/j.ackd.2018.08.010_bib81","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1681\/ASN.2009060640","article-title":"Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification","volume":"21","author":"Shroff","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ackd.2018.08.010_bib82","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1111\/j.1523-1755.2004.66013.x","article-title":"Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure","volume":"66","author":"Neves","year":"2004","journal-title":"Kidney Int"},{"issue":"1-2","key":"10.1053\/j.ackd.2018.08.010_bib83","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.clinbiochem.2013.09.012","article-title":"Product of serum calcium and phosphorus (Ca x PO4) as predictor of cardiovascular disease risk in predialysis patients","volume":"47","author":"Regmi","year":"2014","journal-title":"Clin Biochem"},{"issue":"2","key":"10.1053\/j.ackd.2018.08.010_bib84","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1681\/ASN.2008060609","article-title":"Phosphorus binders and survival on hemodialysis","volume":"20","author":"Isakova","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ackd.2018.08.010_bib85","first-page":"CD006023","article-title":"Phosphate binders for preventing and treating bone disease in chronic kidney disease patients","author":"Navaneethan","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"9900","key":"10.1053\/j.ackd.2018.08.010_bib86","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0140-6736(13)60897-1","article-title":"Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis","volume":"382","author":"Jamal","year":"2013","journal-title":"Lancet"},{"issue":"5","key":"10.1053\/j.ackd.2018.08.010_bib87","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1161\/CIRCHEARTFAILURE.114.001272","article-title":"Elevated parathyroid hormone, but not vitamin D deficiency, is associated with increased risk of heart failure in older men with and without cardiovascular disease","volume":"7","author":"Wannamethee","year":"2014","journal-title":"Circ Heart Fail"},{"issue":"40","key":"10.1053\/j.ackd.2018.08.010_bib88","doi-asserted-by":"crossref","first-page":"e4810","DOI":"10.1097\/MD.0000000000004810","article-title":"Parathyroid hormone and risk of heart failure in the general population: a meta-analysis of prospective studies","volume":"95","author":"Meng","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"10.1053\/j.ackd.2018.08.010_bib89","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.V12102131","article-title":"Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients","volume":"12","author":"Ganesh","year":"2001","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ackd.2018.08.010_bib90","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10741-017-9615-6","article-title":"Phosphate imbalance in patients with heart failure","volume":"22","author":"Christopoulou","year":"2017","journal-title":"Heart Fail Rev"},{"key":"10.1053\/j.ackd.2018.08.010_bib91","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.cca.2014.03.029","article-title":"PTH: potential role in management of heart failure","volume":"433","author":"Gruson","year":"2014","journal-title":"Clin Chim Acta"},{"issue":"3","key":"10.1053\/j.ackd.2018.08.010_bib92","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s007740050101","article-title":"Calcium paradox disease: calcium deficiency prompting secondary hyperparathyroidism and cellular calcium overload","volume":"18","author":"Fujita","year":"2000","journal-title":"J Bone Miner Metab"},{"issue":"1","key":"10.1053\/j.ackd.2018.08.010_bib93","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/cvr\/cvs092","article-title":"Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease","volume":"94","author":"Tomaschitz","year":"2012","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1053\/j.ackd.2018.08.010_bib94","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.metabol.2013.08.016","article-title":"Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease","volume":"63","author":"Tomaschitz","year":"2014","journal-title":"Metabolism"},{"issue":"7","key":"10.1053\/j.ackd.2018.08.010_bib95","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1161\/01.CIR.0000155621.10213.06","article-title":"Hyperparathyroidism and the calcium paradox of aldosteronism","volume":"111","author":"Chhokar","year":"2005","journal-title":"Circulation"},{"issue":"2","key":"10.1053\/j.ackd.2018.08.010_bib96","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10557-012-6378-0","article-title":"Parathyroid hormone, a crucial mediator of pathologic cardiac remodeling in aldosteronism","volume":"27","author":"Rutledge","year":"2013","journal-title":"Cardiovasc Drugs Ther"},{"issue":"10","key":"10.1053\/j.ackd.2018.08.010_bib97","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1681\/ASN.V4101814","article-title":"A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia","volume":"4","author":"Amann","year":"1994","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ackd.2018.08.010_bib98","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/01.ASN.0000056188.23717.E5","article-title":"Beneficial effects of calcimimetics on progression of renal failure and cardiovascular risk factors","volume":"14","author":"Ogata","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ackd.2018.08.010_bib99","doi-asserted-by":"crossref","first-page":"p112","DOI":"10.1159\/000092244","article-title":"Effect of parathyroidectomy on cardiac fibrosis and apoptosis: possible role of aldosterone","volume":"103","author":"Rodriguez-Ayala","year":"2006","journal-title":"Nephron Physiol"},{"issue":"2","key":"10.1053\/j.ackd.2018.08.010_bib100","first-page":"45","article-title":"[Changes in plasma renin and aldosterone after parathyroidectomy in patients with hyperparathyroidism]","volume":"132","author":"Sotornik","year":"1993","journal-title":"Cas Lek Cesk"},{"issue":"5","key":"10.1053\/j.ackd.2018.08.010_bib101","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1530\/eje.0.1380543","article-title":"The effect of surgical treatment on secondary hyperaldosteronism and relative hyperinsulinemia in primary hyperparathyroidism","volume":"138","author":"Kovacs","year":"1998","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1053\/j.ackd.2018.08.010_bib102","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1253\/circj.67.269","article-title":"Marked improvement of left ventricular function after parathyroidectomy in a hemodialysis patient with secondary hyperparathyroidism and left ventricular dysfunction","volume":"67","author":"Nagashima","year":"2003","journal-title":"Circ J"},{"issue":"5","key":"10.1053\/j.ackd.2018.08.010_bib103","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.surg.2007.06.015","article-title":"Parathyroidectomy reduces cardiovascular events and mortality in renal hyperparathyroidism","volume":"142","author":"Costa-Hong","year":"2007","journal-title":"Surgery"},{"issue":"11","key":"10.1053\/j.ackd.2018.08.010_bib104","doi-asserted-by":"crossref","first-page":"e0187025","DOI":"10.1371\/journal.pone.0187025","article-title":"Impact of surgical parathyroidectomy on chronic kidney disease-mineral and bone disorder (CKD-MBD) - a systematic review and meta-analysis","volume":"12","author":"Apetrii","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1053\/j.ackd.2018.08.010_bib105","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10741-011-9232-8","article-title":"Mineral metabolism abnormalities and vitamin D receptor activation in cardiorenal syndromes","volume":"17","author":"Ronco","year":"2012","journal-title":"Heart Fail Rev"},{"issue":"8","key":"10.1053\/j.ackd.2018.08.010_bib106","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.3390\/nu5083005","article-title":"Vitamin D and cardiovascular disease","volume":"5","author":"Kienreich","year":"2013","journal-title":"Nutrients"},{"issue":"3","key":"10.1053\/j.ackd.2018.08.010_bib107","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s00246-012-0489-z","article-title":"Vitamin D deficiency is associated with increased left ventricular mass and diastolic dysfunction in children with chronic kidney disease","volume":"34","author":"Patange","year":"2013","journal-title":"Pediatr Cardiol"},{"issue":"9","key":"10.1053\/j.ackd.2018.08.010_bib108","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.2215\/CJN.02260409","article-title":"Vitamin D and the cardiovascular system","volume":"4","author":"Artaza","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ackd.2018.08.010_bib109","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1161\/01.CIR.96.6.1755","article-title":"Active serum vitamin D levels are inversely correlated with coronary calcification","volume":"96","author":"Watson","year":"1997","journal-title":"Circulation"},{"issue":"4","key":"10.1053\/j.ackd.2018.08.010_bib110","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/CIRCULATIONAHA.107.706127","article-title":"Vitamin D deficiency and risk of cardiovascular disease","volume":"117","author":"Wang","year":"2008","journal-title":"Circulation"},{"issue":"3","key":"10.1053\/j.ackd.2018.08.010_bib111","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ejheart.2008.01.013","article-title":"Poor outcome in end-stage heart failure patients with low circulating calcitriol levels","volume":"10","author":"Zittermann","year":"2008","journal-title":"Eur J Heart Fail"},{"issue":"3-5","key":"10.1053\/j.ackd.2018.08.010_bib112","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jsbmb.2006.12.098","article-title":"Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse","volume":"103","author":"Simpson","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3-5","key":"10.1053\/j.ackd.2018.08.010_bib113","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jsbmb.2006.12.081","article-title":"Heart extracellular matrix gene expression profile in the vitamin D receptor knockout mice","volume":"103","author":"Rahman","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"2","key":"10.1053\/j.ackd.2018.08.010_bib114","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI0215219","article-title":"1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system","volume":"110","author":"Li","year":"2002","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1053\/j.ackd.2018.08.010_bib115","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1093\/ndt\/gft268","article-title":"Vitamin D receptor activation, left ventricular hypertrophy and myocardial fibrosis","volume":"28","author":"Panizo","year":"2013","journal-title":"Nephrol Dial Transpl"},{"issue":"6","key":"10.1053\/j.ackd.2018.08.010_bib116","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/FJC.0b013e3181761906","article-title":"1,25-Dihydroxyvitamin-D3 treatment reduces cardiac hypertrophy and left ventricular diameter in spontaneously hypertensive heart failure-prone (cp\/+) rats independent of changes in serum leptin","volume":"51","author":"Mancuso","year":"2008","journal-title":"J Cardiovasc Pharmacol"},{"issue":"43","key":"10.1053\/j.ackd.2018.08.010_bib117","doi-asserted-by":"crossref","first-page":"16810","DOI":"10.1073\/pnas.0611202104","article-title":"Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals","volume":"104","author":"Bodyak","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1053\/j.ackd.2018.08.010_bib118","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.ahj.2012.09.018","article-title":"Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease","volume":"164","author":"Tamez","year":"2012","journal-title":"Am Heart J"},{"issue":"7","key":"10.1053\/j.ackd.2018.08.010_bib119","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2012.120","article-title":"Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial","volume":"307","author":"Thadhani","year":"2012","journal-title":"JAMA"},{"issue":"1","key":"10.1053\/j.ackd.2018.08.010_bib120","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1681\/ASN.2013010103","article-title":"Effect of paricalcitol on left ventricular mass and function in CKD--the OPERA trial","volume":"25","author":"Wang","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ackd.2018.08.010_bib121","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/ajcn\/83.4.754","article-title":"Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial","volume":"83","author":"Schleithoff","year":"2006","journal-title":"Am J Clin Nutr"},{"issue":"suppl 29","key":"10.1053\/j.ackd.2018.08.010_bib122","first-page":"S54","article-title":"Use of oral and parenteral calcitriol in the treatment of renal osteodystrophy","volume":"38","author":"Coburn","year":"1990","journal-title":"Kidney Int Suppl"},{"issue":"6","key":"10.1053\/j.ackd.2018.08.010_bib123","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1038\/ki.1994.223","article-title":"Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD","volume":"45","author":"Quarles","year":"1994","journal-title":"Kidney Int"},{"issue":"1-3","key":"10.1053\/j.ackd.2018.08.010_bib124","first-page":"223","article-title":"Influence of serum phosphate on the efficacy of oral 1,25-dihydroxyvitamin D3 pulse therapy","volume":"21","author":"Shoji","year":"1995","journal-title":"Miner Electrolyte Metab"},{"issue":"7","key":"10.1053\/j.ackd.2018.08.010_bib125","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/ki.2012.176","article-title":"Update on fibroblast growth factor 23 in chronic kidney disease","volume":"82","author":"Wolf","year":"2012","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ackd.2018.08.010_bib126","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"6","key":"10.1053\/j.ackd.2018.08.010_bib127","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.cmet.2015.09.002","article-title":"Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy","volume":"22","author":"Grabner","year":"2015","journal-title":"Cell Metab"},{"issue":"19","key":"10.1053\/j.ackd.2018.08.010_bib128","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease","volume":"119","author":"Gutierrez","year":"2009","journal-title":"Circulation"},{"issue":"11","key":"10.1053\/j.ackd.2018.08.010_bib129","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1053\/j.ackd.2018.08.010_bib130","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1161\/CIRCHEARTFAILURE.115.002341","article-title":"Fibroblast growth factor 23 is an independent and specific predictor of mortality in patients with heart failure and reduced ejection fraction","volume":"8","author":"Koller","year":"2015","journal-title":"Circ Heart Fail"},{"issue":"2","key":"10.1053\/j.ackd.2018.08.010_bib131","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1681\/ASN.2013050465","article-title":"Fibroblast growth factor-23 and cardiovascular events in CKD","volume":"25","author":"Scialla","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"10.1053\/j.ackd.2018.08.010_bib132","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1172\/JCI61405","article-title":"FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality","volume":"122","author":"Shalhoub","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ackd.2018.08.010_bib133","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fendo.2018.00048","article-title":"Targeting fibroblast growth factor 23 signaling with Antibodies and inhibitors, is there a rationale?","volume":"9","author":"Fukumoto","year":"2018","journal-title":"Front Endocrinol (lausanne)"},{"issue":"4 Suppl A","key":"10.1053\/j.ackd.2018.08.010_bib134","doi-asserted-by":"crossref","first-page":"6A","DOI":"10.1016\/0735-1097(93)90455-A","article-title":"The epidemiology of heart failure: the Framingham Study","volume":"22","author":"Ho","year":"1993","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1053\/j.ackd.2018.08.010_bib135","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/archinte.161.7.996","article-title":"Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study","volume":"161","author":"He","year":"2001","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1053\/j.ackd.2018.08.010_bib136","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1161\/01.HYP.0000102971.85504.7c","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention","volume":"42","author":"Sarnak","year":"2003","journal-title":"Hypertension"},{"issue":"3","key":"10.1053\/j.ackd.2018.08.010_bib137","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1681\/ASN.V133745","article-title":"Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States","volume":"13","author":"Muntner","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ackd.2018.08.010_bib138","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0272-6386(03)00916-8","article-title":"A population-based study of the incidence and outcomes of diagnosed chronic kidney disease","volume":"42","author":"Drey","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"9438","key":"10.1053\/j.ackd.2018.08.010_bib139","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"issue":"1","key":"10.1053\/j.ackd.2018.08.010_bib140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1542-4758.2006.01168.x","article-title":"Mechanisms of dyslipidemia of chronic renal failure","volume":"10","author":"Vaziri","year":"2006","journal-title":"Hemodial Int"},{"issue":"5","key":"10.1053\/j.ackd.2018.08.010_bib141","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/ki.1981.62","article-title":"Lipid abnormalities in uremia, dialysis, and transplantation","volume":"19","author":"Chan","year":"1981","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ackd.2018.08.010_bib142","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/HYPERTENSIONAHA.110.164780","article-title":"Early sympathetic activation in the initial clinical stages of chronic renal failure","volume":"57","author":"Grassi","year":"2011","journal-title":"Hypertension"},{"issue":"27","key":"10.1053\/j.ackd.2018.08.010_bib143","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1056\/NEJM199212313272704","article-title":"Sympathetic overactivity in patients with chronic renal failure","volume":"327","author":"Converse","year":"1992","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1053\/j.ackd.2018.08.010_bib144","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.semnephrol.2003.11.008","article-title":"Oxidative stress in hypertension and chronic kidney disease: role of angiotensin II","volume":"24","author":"Agarwal","year":"2004","journal-title":"Semin Nephrol"},{"issue":"11","key":"10.1053\/j.ackd.2018.08.010_bib145","doi-asserted-by":"crossref","first-page":"23011","DOI":"10.3390\/ijms141123011","article-title":"Pathogenesis of chronic cardiorenal syndrome: is there a role for oxidative stress?","volume":"14","author":"Rubattu","year":"2013","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1053\/j.ackd.2018.08.010_bib146","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1113\/expphysiol.1997.sp004024","article-title":"Oxidative stress: oxidants and antioxidants","volume":"82","author":"Sies","year":"1997","journal-title":"Exp Physiol"},{"issue":"7","key":"10.1053\/j.ackd.2018.08.010_bib147","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCRESAHA.110.232306","article-title":"Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure","volume":"108","author":"Dai","year":"2011","journal-title":"Circ Res"},{"issue":"7","key":"10.1053\/j.ackd.2018.08.010_bib148","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.114.001598","article-title":"Apocynin attenuates cardiac injury in type 4 cardiorenal syndrome via suppressing cardiac fibroblast growth Factor-2 with oxidative stress inhibition","volume":"4","author":"Liu","year":"2015","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1053\/j.ackd.2018.08.010_bib149","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/cvr\/cvn184","article-title":"Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylation","volume":"80","author":"Rosca","year":"2008","journal-title":"Cardiovasc Res"},{"issue":"3","key":"10.1053\/j.ackd.2018.08.010_bib150","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1046\/j.1523-1755.2000.00281.x","article-title":"Total nitric oxide production is low in patients with chronic renal disease","volume":"58","author":"Schmidt","year":"2000","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ackd.2018.08.010_bib151","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1527-5299.2002.00714.x","article-title":"Oxidative stress and endothelial dysfunction in heart failure","volume":"8","author":"Sharma","year":"2002","journal-title":"Congest Heart Fail"},{"issue":"3","key":"10.1053\/j.ackd.2018.08.010_bib152","doi-asserted-by":"crossref","first-page":"H845","DOI":"10.1152\/ajpheart.00261.2011","article-title":"Subtotal nephrectomy plus coronary ligation leads to more pronounced damage in both organs than either nephrectomy or coronary ligation","volume":"302","author":"Bongartz","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"23","key":"10.1053\/j.ackd.2018.08.010_bib153","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1161\/CIRCULATIONAHA.109.886473","article-title":"Cardiorenal syndrome: new perspectives","volume":"121","author":"Bock","year":"2010","journal-title":"Circulation"},{"issue":"6","key":"10.1053\/j.ackd.2018.08.010_bib154","first-page":"CD008684","article-title":"Coenzyme Q10 for heart failure","author":"Madmani","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1053\/j.ackd.2018.08.010_bib155","doi-asserted-by":"crossref","first-page":"e56803","DOI":"10.1371\/journal.pone.0056803","article-title":"Effect of antioxidant vitamin supplementation on cardiovascular outcomes: a meta-analysis of randomized controlled trials","volume":"8","author":"Ye","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1053\/j.ackd.2018.08.010_bib156","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/ki.1989.192","article-title":"Impact of left ventricular hypertrophy on survival in end-stage renal disease","volume":"36","author":"Silberberg","year":"1989","journal-title":"Kidney Int"},{"issue":"24","key":"10.1053\/j.ackd.2018.08.010_bib157","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1056\/NEJMoa1001593","article-title":"In-center hemodialysis six times per week versus three times per week","volume":"363","author":"Group FHNT","year":"2010","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1053\/j.ackd.2018.08.010_bib158","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/CIRCIMAGING.111.969923","article-title":"Determinants of left ventricular mass in patients on hemodialysis: frequent Hemodialysis Network (FHN) Trials","volume":"5","author":"Chan","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"issue":"10","key":"10.1053\/j.ackd.2018.08.010_bib159","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/ki.2011.213","article-title":"The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial","volume":"80","author":"Rocco","year":"2011","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ackd.2018.08.010_bib160","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/00000441-194907000-00011","article-title":"Continuous peritoneal irrigation in the treatment of intractable edema of cardiac origin","volume":"218","author":"Schneierson","year":"1949","journal-title":"Am J Med Sci"},{"issue":"1","key":"10.1053\/j.ackd.2018.08.010_bib161","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3747\/pdi.2010.00007","article-title":"Peritoneal dialysis is not associated with myocardial stunning","volume":"31","author":"Selby","year":"2011","journal-title":"Perit Dial Int"},{"issue":"2","key":"10.1053\/j.ackd.2018.08.010_bib162","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000380915","article-title":"Peritoneal dialysis in patients with refractory congestive heart failure: a systematic review","volume":"5","author":"Lu","year":"2015","journal-title":"Cardiorenal Med"},{"issue":"1","key":"10.1053\/j.ackd.2018.08.010_bib163","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jtcvs.2013.09.017","volume":"147","author":"Karamlou","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"10.1053\/j.ackd.2018.08.010_bib164","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.transproceed.2016.11.040","article-title":"Combined heart and kidney transplantation: a 23-year experience","volume":"49","author":"Awad","year":"2017","journal-title":"Transplant Proc"},{"issue":"4","key":"10.1053\/j.ackd.2018.08.010_bib165","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.transproceed.2010.03.064","article-title":"Combined heart and kidney transplantation: long-term analysis of renal function and major adverse events at 20 years","volume":"42","author":"Bruschi","year":"2010","journal-title":"Transplant Proc"},{"issue":"23","key":"10.1053\/j.ackd.2018.08.010_bib166","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)","volume":"316","author":"Group","year":"1987","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1053\/j.ackd.2018.08.010_bib167","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","author":"Investigators","year":"1991","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1053\/j.ackd.2018.08.010_bib168","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1001\/jama.1995.03520420066040","article-title":"Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials","volume":"273","author":"Garg","year":"1995","journal-title":"JAMA"},{"issue":"5","key":"10.1053\/j.ackd.2018.08.010_bib169","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.ijcard.2012.10.007","article-title":"The past, present and future of renin-angiotensin aldosterone system inhibition","volume":"167","author":"Mentz","year":"2013","journal-title":"Int J Cardiol"},{"issue":"9704","key":"10.1053\/j.ackd.2018.08.010_bib170","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/S0140-6736(09)61913-9","article-title":"Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial","volume":"374","author":"Konstam","year":"2009","journal-title":"Lancet"},{"issue":"7","key":"10.1053\/j.ackd.2018.08.010_bib171","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/eurheartj\/ehq502","article-title":"Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial","volume":"32","author":"Pitt","year":"2011","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1053\/j.ackd.2018.08.010_bib172","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/ejhf.402","article-title":"Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors","volume":"17","author":"Pitt","year":"2015","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10.1053\/j.ackd.2018.08.010_bib173","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1410853","article-title":"Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors","volume":"372","author":"Weir","year":"2015","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1053\/j.ackd.2018.08.010_bib174","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/ejhf.300","article-title":"Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS-9) in heart failure patients: results from a phase 3 randomized, double-blind, placebo-controlled trial","volume":"17","author":"Anker","year":"2015","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"10.1053\/j.ackd.2018.08.010_bib175","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1161\/01.CIR.0000143892.84582.60","article-title":"Effect of pravastatin on cardiovascular events in people with chronic kidney disease","volume":"110","author":"Tonelli","year":"2004","journal-title":"Circulation"},{"issue":"9784","key":"10.1053\/j.ackd.2018.08.010_bib176","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"issue":"2","key":"10.1053\/j.ackd.2018.08.010_bib177","first-page":"CD007784","article-title":"HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis","author":"Navaneethan","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1053\/j.ackd.2018.08.010_bib178","doi-asserted-by":"crossref","first-page":"251","DOI":"10.7326\/0003-4819-157-4-201208210-00005","article-title":"Lipid-lowering therapy in persons with chronic kidney disease: a systematic review and meta-analysis","volume":"157","author":"Upadhyay","year":"2012","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1053\/j.ackd.2018.08.010_bib179","doi-asserted-by":"crossref","first-page":"263","DOI":"10.7326\/0003-4819-157-4-201208210-00007","article-title":"Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis","volume":"157","author":"Palmer","year":"2012","journal-title":"Ann Intern Med"},{"issue":"9374","key":"10.1053\/j.ackd.2018.08.010_bib180","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(03)13638-0","article-title":"Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial","volume":"361","author":"Holdaas","year":"2003","journal-title":"Lancet"},{"issue":"3","key":"10.1053\/j.ackd.2018.08.010_bib181","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1053\/j.ackd.2018.08.010_bib182","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","author":"Fellstrom","year":"2009","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1053\/j.ackd.2018.08.010_bib183","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/ki.2014.31","article-title":"Kidney disease: improving global outcomes lipid guideline development work group M. KDIGO clinical practice guideline for lipid management in CKD: summary of recommendation statements and clinical approach to the patient","volume":"85","author":"Wanner","year":"2014","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ackd.2018.08.010_bib184","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1159\/000351175","article-title":"Cardiovascular toxicity of epoetin-alfa in patients with chronic kidney disease","volume":"37","author":"McCullough","year":"2013","journal-title":"Am J Nephrol"},{"issue":"1","key":"10.1053\/j.ackd.2018.08.010_bib185","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/ndt\/gfg458","article-title":"Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"19","author":"Locatelli","year":"2004","journal-title":"Nephrol Dial Transpl"},{"issue":"9","key":"10.1053\/j.ackd.2018.08.010_bib186","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJM199808273390903","article-title":"The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin","volume":"339","author":"Besarab","year":"1998","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.ackd.2018.08.010_bib187","doi-asserted-by":"crossref","first-page":"23","DOI":"10.7326\/0003-4819-153-1-201007060-00252","article-title":"Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease","volume":"153","author":"Palmer","year":"2010","journal-title":"Ann Intern Med"},{"issue":"13","key":"10.1053\/j.ackd.2018.08.010_bib188","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJMoa1214865","article-title":"Treatment of anemia with darbepoetin alfa in systolic heart failure","volume":"368","author":"Swedberg","year":"2013","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.ackd.2018.08.010_bib189","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.krcp.2013.01.001","article-title":"Understanding and exploiting hepcidin as an indicator of anemia due to chronic kidney disease","volume":"32","author":"Larson","year":"2013","journal-title":"Kidney Res Clin Pract"},{"issue":"25","key":"10.1053\/j.ackd.2018.08.010_bib190","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1053\/j.ackd.2018.08.010_bib191","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiencydagger","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur Heart J"},{"issue":"26","key":"10.1053\/j.ackd.2018.08.010_bib192","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","article-title":"Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis","volume":"367","author":"Investigators","year":"2012","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1053\/j.ackd.2018.08.010_bib193","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1001\/jamainternmed.2017.4831","article-title":"Outcomes associated with left ventricular assist devices among recipients with and without end-stage renal disease","volume":"178","author":"Bansal","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10.1053\/j.ackd.2018.08.010_bib194","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2215\/CJN.04670417","article-title":"Left ventricular assist devices and the kidney","volume":"13","author":"Ross","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ackd.2018.08.010_bib195","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/j.ajkd.2017.09.019","article-title":"Left ventricular assist devices, kidney disease, and dialysis","volume":"71","author":"Roehm","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ackd.2018.08.010_bib196","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/MAJ.0000000000000221","article-title":"Secondary hemosiderosis on kidney biopsy in a patient with a left ventricular assist device","volume":"347","author":"Rodrigues","year":"2014","journal-title":"Am J Med Sci"},{"issue":"1","key":"10.1053\/j.ackd.2018.08.010_bib197","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jtcvs.2007.12.023","article-title":"Reduced pulsatility induces periarteritis in kidney: role of the local renin-angiotensin system","volume":"136","author":"Ootaki","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"10.1053\/j.ackd.2018.08.010_bib198","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10741-015-9481-z","article-title":"Left ventricular assist devices: a kidney's perspective","volume":"20","author":"Tromp","year":"2015","journal-title":"Heart Fail Rev"}],"container-title":["Advances in Chronic Kidney Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559518301447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559518301447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:00:52Z","timestamp":1761548452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1548559518301447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":198,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1548559518301447"],"URL":"https:\/\/doi.org\/10.1053\/j.ackd.2018.08.010","relation":{},"ISSN":["1548-5595"],"issn-type":[{"value":"1548-5595","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Working Toward an Improved Understanding of Chronic Cardiorenal Syndrome Type 4","name":"articletitle","label":"Article Title"},{"value":"Advances in Chronic Kidney Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ackd.2018.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the National Kidney Foundation, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}